128 related articles for article (PubMed ID: 37903117)
1. Does the ypTNM-stage adequately predict long-term survival rates in gastric cancer patients receiving neoadjuvant chemotherapy followed by radical resection?
Sandø AD; Grønbech JE; Bringeland EA
Acta Oncol; 2023 Dec; 62(12):1846-1853. PubMed ID: 37903117
[TBL] [Abstract][Full Text] [Related]
2. The value of restaging CT following neoadjuvant chemotherapy for resectable gastric cancer. A population-based study.
Sandø AD; Fougner R; Grønbech JE; Bringeland EA
World J Surg Oncol; 2021 Jul; 19(1):212. PubMed ID: 34256790
[TBL] [Abstract][Full Text] [Related]
3. Different prognostic implication of ypTNM stage and pTNM stage for gastric cancer: a propensity score-matched analysis.
Li Z; Wang Y; Ying X; Shan F; Wu Z; Zhang L; Li S; Jia Y; Ren H; Ji J
BMC Cancer; 2019 Jan; 19(1):80. PubMed ID: 30651085
[TBL] [Abstract][Full Text] [Related]
4. ypTNM staging after neoadjuvant chemotherapy in the Chinese gastric cancer population: an evaluation on the prognostic value of the AJCC eighth edition cancer staging system.
Li Z; Wang Y; Shan F; Ying X; Wu Z; Xue K; Miao R; Zhang Y; Ji J
Gastric Cancer; 2018 Nov; 21(6):977-987. PubMed ID: 29748876
[TBL] [Abstract][Full Text] [Related]
5. Significance of neoadjuvant downstaging in gastric adenocarcinoma.
Prasad P; Sivaharan A; Navidi M; Fergie BH; Griffin SM; Phillips AW
Surgery; 2022 Aug; 172(2):593-601. PubMed ID: 35400501
[TBL] [Abstract][Full Text] [Related]
6. Proposed modification of the eighth edition of the AJCC-ypTNM staging system of esophageal squamous cell cancer treated with neoadjuvant chemotherapy: Unification of the AJCC staging system and the Japanese classification.
Oshikiri T; Goto H; Kato T; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Fujino Y; Tominaga M; Kakeji Y
Eur J Surg Oncol; 2022 Aug; 48(8):1760-1767. PubMed ID: 35094909
[TBL] [Abstract][Full Text] [Related]
7. Validation of the post-neoadjuvant staging system of the American joint committee on cancer, 8th edition, in patients treated with neoadjuvant chemoradiotherapy followed by curative esophagectomy for localized esophageal squamous cell carcinoma.
Kang J; Lee HP; Kim HR; Kim JH; Jung HY; Lee GH; Song HJ; Kim DH; Choi KD; Ahn JY; Ryu JS; Cho KJ; Lee MY; Kim SB; Kim YH; Park SR
Surg Oncol; 2020 Dec; 35():491-497. PubMed ID: 33130441
[TBL] [Abstract][Full Text] [Related]
8. [Exploration of potential beneficial people of neoadjuvant chemotherapy based on clinical staging in gastric cancer: a single center retrospective study].
Wang YK; Wang YC; Shan F; Tang L; Li ZY; Ji JF
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):152-157. PubMed ID: 32074795
[No Abstract] [Full Text] [Related]
9. Prognostic differences in 8th edition TNM staging of esophagogastric adenocarcinoma after neoadjuvant treatment.
Sisic L; Blank S; Nienhüser H; Dorr S; Haag GM; Jäger D; Bruckner T; Müller-Stich BP; Ott K; Büchler MW; Ulrich A; Schmidt T
Eur J Surg Oncol; 2018 Oct; 44(10):1646-1656. PubMed ID: 30082176
[TBL] [Abstract][Full Text] [Related]
10. A Novel Tumor Staging System Incorporating Tumor Regression Grade (TRG) With Lymph Node Status (ypN-Category) Results in Better Prognostication Than ypTNM Stage Groups After Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma.
Wong IYH; Chung JCY; Zhang RQ; Gao X; Lam KO; Kwong DLW; Chao YK; Law SYK
Ann Surg; 2022 Nov; 276(5):784-791. PubMed ID: 35876374
[TBL] [Abstract][Full Text] [Related]
11. Response Evaluation after Neoadjuvant Chemotherapy for Resectable Gastric Cancer.
Sandø AD; Fougner R; Røyset ES; Dai HY; Grønbech JE; Bringeland EA
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190246
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic analysis of neoadjuvant chemotherapy for locally advanced gastric cancer with propensity score matching method].
Peng L; Yang W; Zhang Z; Zhi C; Zhou X; Liu H; Hua Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1148-1153. PubMed ID: 30370514
[TBL] [Abstract][Full Text] [Related]
13. Modified ypTNM Staging Classification for Gastric Cancer after Neoadjuvant Therapy: A Multi-Institutional Study.
Zhong Q; Chen QY; Parisi A; Ma YB; Lin GT; Desiderio J; Yan S; Xie JW; Wang JB; Hou JF; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Liu ZY; Que SJ; Li P; Zheng CH; Huang CM
Oncologist; 2021 Jan; 26(1):e99-e110. PubMed ID: 32864840
[TBL] [Abstract][Full Text] [Related]
14. Nodal downstaging to ypN0 after neoadjuvant chemotherapy positively impacts on survival of cT4N+ GC/GEJ patients.
Wu L; Xing Z; Huang M; Yu H; Qin Y; Jin Q; Zhou Z; Chen J
J Surg Oncol; 2022 Dec; 126(8):1403-1412. PubMed ID: 36001384
[TBL] [Abstract][Full Text] [Related]
15. Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus.
Noble F; Nolan L; Bateman AC; Byrne JP; Kelly JJ; Bailey IS; Sharland DM; Rees CN; Iveson TJ; Underwood TJ; Bateman AR
World J Gastroenterol; 2013 Dec; 19(48):9282-93. PubMed ID: 24409055
[TBL] [Abstract][Full Text] [Related]
16. Total Lymph Node Yield Is Associated with Prolonged Survival after Neoadjuvant Chemotherapy in ypN0 Gastric Cancer Patients.
Li W; Shao X; Ma F; Wang B; Xue L; Hu H; Kang W; Xiong J; Tian Y
Oncol Res Treat; 2023; 46(7-8):287-295. PubMed ID: 37302386
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of the treatment response of regional lymph nodes and the refinement of the current TNM staging system in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
Cui J; Zhang L; Yang L; Zhu YL; Fang H; Chen B; Ning Y; Zhang HZ
Cancer Med; 2020 Dec; 9(24):9373-9384. PubMed ID: 33079470
[TBL] [Abstract][Full Text] [Related]
18. [Postoperative complications and their influence on the prognosis factors in gastric cancer patients receiving neoadjuvant treatment].
Wang TB; Mao QK; Zhang XJ; Zhou H; Guo CG; Chen YT; Zhao DB
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):160-166. PubMed ID: 33508922
[No Abstract] [Full Text] [Related]
19. Correlation of pathological complete response with survival after neoadjuvant chemotherapy in gastric or gastroesophageal junction cancer treated with radical surgery: A meta-analysis.
Li Z; Shan F; Wang Y; Zhang Y; Zhang L; Li S; Jia Y; Xue K; Miao R; Li Z; Ji J
PLoS One; 2018; 13(1):e0189294. PubMed ID: 29370182
[TBL] [Abstract][Full Text] [Related]
20. [Clinical value of superior mesenteric vein (No.14v) lymph node dissection in D2 gastrectomy for locally advanced distal gastric cancer].
Lu W; Zeng X; Li N; Liu H
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1136-1141. PubMed ID: 30370512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
